TY - JOUR
T1 - Screening, diagnosis and management of human cysticercosis and Taenia solium taeniasis
T2 - technical recommendations by the COHEMI project study group
AU - The COHEMI Project Study Group
AU - Zammarchi, Lorenzo
AU - Bonati, Maurizio
AU - Strohmeyer, Marianne
AU - Albonico, Marco
AU - Requena-Méndez, Ana
AU - Bisoffi, Zeno
AU - Nicoletti, Alessandra
AU - García, Hector H.
AU - Bartoloni, Alessandro
AU - Pandolfini, Chiara
AU - Severino, Francesca
AU - Confalonieri, Valeria
AU - Tognoni, Gianni
AU - Buonfrate, Dora
AU - Angheben, Andrea
AU - Bartalesi, Filippo
AU - Muñoz, Jose
AU - Roura, Maria
AU - Ventura, Laia
AU - Pool, Robert
AU - Pell, Christopher
AU - Hardon, Anita
AU - Chiodini, Peter
AU - Moreira, Juan
AU - Anselmi, Mariella
AU - Sempértegui, Roberto
AU - Gotuzzo, Eduardo
AU - Mena, Maria Alejandra
AU - Liendo, Carola
AU - Bustos, Javier
AU - Santivañez, Saul
AU - Torrico, Faustino
AU - Lozano, Daniel
AU - Cabrera, Teresa Hinojosa
AU - Morón, Javier Ochoa
AU - Cuellar, Ignacio Abapori
AU - Suarez, Jaime Amorós
AU - Rojas, Guido Chumiray
AU - Bruno, Elisa
N1 - Publisher Copyright:
© 2017 John Wiley & Sons Ltd
PY - 2017/7/1
Y1 - 2017/7/1
N2 - Neurocysticercosis, the central nervous system's localised form of cysticercosis, is considered to be the leading cause of epilepsy in the developing world. In Europe, the disease is mainly imported and affects both immigrants and travellers. However, autochthonous cases of cysticercosis in low-endemic countries could also originate from Taenia solium carriers (migrants or travellers) who acquired taeniasis overseas. Management of cysticercosis is a challenge for European healthcare providers as they are often hardly aware of this infection and have little familiarity in managing this disease. This study provides a summary of recommendations concerning screening, diagnosis and management of cysticercosis and T. solium taeniasis in Europe drawn up by nine experts in migrant health and imported diseases with experience in cysticercosis and T. solium taeniasis.
AB - Neurocysticercosis, the central nervous system's localised form of cysticercosis, is considered to be the leading cause of epilepsy in the developing world. In Europe, the disease is mainly imported and affects both immigrants and travellers. However, autochthonous cases of cysticercosis in low-endemic countries could also originate from Taenia solium carriers (migrants or travellers) who acquired taeniasis overseas. Management of cysticercosis is a challenge for European healthcare providers as they are often hardly aware of this infection and have little familiarity in managing this disease. This study provides a summary of recommendations concerning screening, diagnosis and management of cysticercosis and T. solium taeniasis in Europe drawn up by nine experts in migrant health and imported diseases with experience in cysticercosis and T. solium taeniasis.
KW - Taenia solium
KW - cysticercosis
KW - epilepsy
KW - neurocysticercosis
KW - recommendations
KW - taeniasis
UR - https://www.scopus.com/pages/publications/85020073135
U2 - 10.1111/tmi.12887
DO - 10.1111/tmi.12887
M3 - Artículo
C2 - 28449318
AN - SCOPUS:85020073135
SN - 1360-2276
VL - 22
SP - 881
EP - 894
JO - Tropical Medicine and International Health
JF - Tropical Medicine and International Health
IS - 7
ER -